Form 4: Apollomics CEO Chen Hung-Wen Executes RSU Vesting

Apollomics CEO Chen Hung-Wen acquired 5,000 Class A Ordinary Shares through the vesting of restricted stock units.

Summary

• CEO Chen Hung-Wen acquired 5,000 Class A Ordinary Shares on June 15, 2026, via the vesting of restricted stock units (RSUs).
• The transaction resulted in a direct ownership increase of 5,000 shares, bringing the total direct holdings to 148,334 shares.
• The reporting person maintains indirect ownership of 763,028 shares through King Regent Management Limited.
• The RSU vesting follows a previously established grant schedule reported in March and April 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a routine administrative vesting of equity compensation rather than a discretionary market transaction.

Positives

• The transaction reflects the standard vesting of equity compensation for the CEO, aligning management interests with shareholders.

Negatives

• None identified; this is a routine equity compensation event.

Risks

• The reporting person disclaims beneficial ownership of shares held by King Regent Management Limited except to the extent of pecuniary interest, which may complicate ownership transparency.

Future Outlook

The filing notes that an additional 5,000 shares are scheduled to vest on September 15, 2026.

Management Comments

• The reporting person is the sole director and shareholder of King Regent Management Limited and has voting and dispositive power over the shares held by King Regent Management Limited.

Industry Context

StockSavvy.ai notes that routine RSU vesting for executive leadership is a standard corporate governance practice in the biotechnology sector, signaling continued retention and alignment of management.

Comparison to Industry Standards

• The disclosure of RSU vesting schedules is consistent with standard SEC reporting requirements for publicly traded biotech firms.
• The use of holding companies for executive share ownership is common practice among international executives in the U.S. markets.

Related Party Transactions

• The reporting person maintains control over King Regent Management Limited, which holds 763,028 shares of the issuer.

Stakeholder Impact

• Minimal impact on shareholders as this is a pre-planned equity compensation event.

Next Steps

• Scheduled vesting of 5,000 RSUs on September 15, 2026.

Key Dates

Keywords

Apollomics, APLM, Form 4, Insider Trading, Equity Compensation, Restricted Stock Units, Chen Hung-Wen